Northern Trust
FBLG icon

Northern Trust’s FibroBiologics FBLG Stock Holding History

Northern Trust’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,384
Closed -$10.7K – 4547
2025
Q4 		$10.7K Hold
2,384
– – ﹤0.01% 4431
2025
Q3 		$26K Sell
2,384
-22
-0.9% -$263 ﹤0.01% 4355
2025
Q2 		$29.9K Sell
2,406
-7,900
-77% -$142K ﹤0.01% 4307
2025
Q1 		$186K Sell
10,306
-465
-4% -$13.3K ﹤0.01% 3967
2024
Q4 		$431K Buy
10,771
+247
+2% +$13.3K ﹤0.01% 3705
2024
Q3 		$650K Buy
+10,524
New +$699K ﹤0.01% 3498

Other funds holding FBLG

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FEG
Fund Evaluation Group Cincinnati, Ohio $3.25B AUM 14.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $970M AUM 19.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM

Northern Trust's FBLG Position: Q1 2026 in Review

Northern Trust sold out of FibroBiologics (FBLG) in Q1 2026, closing a stake of 2,384 shares — an estimated $10.7K sold.

Northern Trust first reported a position in FBLG in Q3 2024 and held it in 6 quarters. The position peaked at $650K in Q3 2024. 17 funds tracked by Wall St. Rank hold FBLG as of Q1 2026.

  • Northern Trust reported no remaining FibroBiologics position as of Q1 2026 after selling out during the quarter.
  • Northern Trust sold 2,384 FibroBiologics shares in Q1 2026, an estimated $10.7K.
  • Northern Trust first reported a position in FibroBiologics in Q3 2024 and held it in 6 quarters.
  • Northern Trust's FibroBiologics position peaked at $650K in Q3 2024.
  • 17 funds tracked by Wall St. Rank held FibroBiologics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.